Comparative and cost-effectiveness of oxaliplatin-based or irinotecan-based regimens compared with 5-fluorouracil/leucovorin alone among US elderly stage IV colon cancer patients

Mullins C.D.FEI-YUAN HSIAOOnukwugha E.Pandya N.B.Hanna N.2022-09-192022-09-1920120008543Xhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84861886858&doi=10.1002%2fcncr.26613&partnerID=40&md5=a967844a6129c0b40d25663b2a02320chttps://scholars.lib.ntu.edu.tw/handle/123456789/620988[SDGs]SDG3Comparative and cost-effectiveness of oxaliplatin-based or irinotecan-based regimens compared with 5-fluorouracil/leucovorin alone among US elderly stage IV colon cancer patientsjournal article10.1002/cncr.26613220207392-s2.0-84861886858